Dr. Li is a scientifically trained business strategist with a Ph.D. in Biomedical Sciences and an MBA from Johns Hopkins University. With experience spanning academic research, pharma R&D, biotech investment, and business development, she brings a rare combination of technical depth, commercial insight, and operational expertise. Dr. Li specializes in drug discovery, IND-enabling development, biomarker strategy, BD partnership sourcing, and venture evaluation. Leveraging a global network across biotech, pharma, VCs, and CROs, she helps companies forge new partnerships, expand market presence, and accelerate growth. She transforms complex science into actionable strategy—strengthening pipelines and bringing innovation to market faster.